Correlation Between Oncolytics Biotech and AstraZeneca PLC
Can any of the company-specific risk be diversified away by investing in both Oncolytics Biotech and AstraZeneca PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncolytics Biotech and AstraZeneca PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncolytics Biotech and AstraZeneca PLC ADR, you can compare the effects of market volatilities on Oncolytics Biotech and AstraZeneca PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncolytics Biotech with a short position of AstraZeneca PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncolytics Biotech and AstraZeneca PLC.
Diversification Opportunities for Oncolytics Biotech and AstraZeneca PLC
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Oncolytics and AstraZeneca is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Oncolytics Biotech and AstraZeneca PLC ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AstraZeneca PLC ADR and Oncolytics Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncolytics Biotech are associated (or correlated) with AstraZeneca PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AstraZeneca PLC ADR has no effect on the direction of Oncolytics Biotech i.e., Oncolytics Biotech and AstraZeneca PLC go up and down completely randomly.
Pair Corralation between Oncolytics Biotech and AstraZeneca PLC
Given the investment horizon of 90 days Oncolytics Biotech is expected to under-perform the AstraZeneca PLC. In addition to that, Oncolytics Biotech is 4.23 times more volatile than AstraZeneca PLC ADR. It trades about -0.21 of its total potential returns per unit of risk. AstraZeneca PLC ADR is currently generating about 0.0 per unit of volatility. If you would invest 6,663 in AstraZeneca PLC ADR on October 23, 2024 and sell it today you would lose (3.00) from holding AstraZeneca PLC ADR or give up 0.05% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Oncolytics Biotech vs. AstraZeneca PLC ADR
Performance |
| Timeline |
| Oncolytics Biotech |
| AstraZeneca PLC ADR |
Oncolytics Biotech and AstraZeneca PLC Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oncolytics Biotech and AstraZeneca PLC
The main advantage of trading using opposite Oncolytics Biotech and AstraZeneca PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncolytics Biotech position performs unexpectedly, AstraZeneca PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will offset losses from the drop in AstraZeneca PLC's long position.| Oncolytics Biotech vs. Scpharmaceuticals | Oncolytics Biotech vs. Milestone Pharmaceuticals | Oncolytics Biotech vs. Seres Therapeutics | Oncolytics Biotech vs. DiaMedica Therapeutics |
| AstraZeneca PLC vs. DiaMedica Therapeutics | AstraZeneca PLC vs. Seres Therapeutics | AstraZeneca PLC vs. Inhibikase Therapeutics | AstraZeneca PLC vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |